$TOL

Analysts Offer Insights on Consumer Cyclical Companies: Toll Brothers (TOL), Gentex (GNTX) and TJX Companies (TJX)

Analysts from BTIG, UBS, and Goldman Sachs provided updates on Toll Brothers (TOL), Gentex (GNTX), and TJX Companies (TJX). TOL has a Moderate Buy consensus with a $168.58 average price target. GNTX has a Hold consensus with a $26.00 average price target. TJX has a Strong Buy consensus with a $175.31 average price target.

Original reporting
Published Aug 21, 2026, 10:28 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 10:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Analysts Offer Insights on Consumer Cyclical Companies: Toll Brothers (TOL), Gentex (GNTX) and TJX Companies (TJX) — source image
Decision brief

The 30-second read

$TOLNeutralLow
01

Why it matters

These updates may modestly affect each stock's short‑term price action but lack a strong catalyst.

02

Market read

Provides fresh analyst viewpoints and price targets for TOL, GNTX, and TJX, offering modest trading ideas.

03

What to watch

Potential impact of upcoming earnings season and macro‑economic trends on consumer discretionary demand.

Relevance 6/10Novelty 5/10Timing: today

Background

Analyst rating updates for three consumer‑cyclical companies were released, providing new price targets and sentiment.

Company-level read

Ticker impact

$TOLNeutralMedium confidence
Context

BTIG analyst Ryan Gilbert maintained a Hold rating on Toll Brothers and set a $168.58 price target, implying upside.

Expected impact

Limited upside potential; price may trade near current levels.

Evidence & confidence

Hold rating and price target suggest no immediate catalyst, but upside indicates room for modest gains.

$GNTXNeutralMedium confidence
Context

UBS analyst Joseph Spak maintained a Hold rating on Gentex with a $25 price target, noting the stock near its 52‑week low.

Expected impact

Potential modest upside if price rebounds toward target.

Evidence & confidence

Analyst view signals limited downside risk but modest upside, no strong catalyst.

$TJXBullishMedium confidence
Context

UBS analyst Jay Sole reiterated a Buy rating on TJX Companies with a $198 price target, indicating 21.6% upside.

Expected impact

Likely upward pressure toward target levels.

Evidence & confidence

Analyst upgrade and high upside suggest potential price appreciation in the near term.

Market effects

Analyst coverage highlights consumer‑cyclical sector sentiment and may influence peer valuations.

U.S. consumer‑cyclical stocks may see modest re‑rating activity.

Limited to U.S. equities; no broader macro impact.

Counterpoint

Hold ratings could be overly cautious; price targets may underestimate upside if consumer spending improves.

Key entities

  • Ryan Gilbert

    BTIG analyst covering Toll Brothers.

  • Joseph Spak

    UBS analyst covering Gentex.

  • Jay Sole

    UBS analyst covering TJX Companies.

Related articles

$TOLMed

This luxury homebuilder's stock is too cheap to pass up, Morgan Stanley says

Morgan Stanley initiated coverage of Toll Brothers with an overweight rating and $159 price target, citing resilient margins and a low P/E ratio. Shares have fallen 14% in three months due to mortgage rate fluctuations and rising homebuilding costs. Analyst Adam Kramer highlights the company's affluent buyer base and favorable positioning in the housing market. 14 of 19 analysts rate the stock buy or strong buy.

$TJXHighAI 8/10

TJX Raises Fiscal 2027 Outlook as Q2 Results Show Broad-Based Growth

TJX raised its fiscal 2027 profit and earnings outlook after Q2 results exceeded expectations. Adjusted earnings rose 11% to $1.22 per share, and net sales increased 5% to $15.18 billion. Management also increased its long-term store target. Marmaxx, the largest division, showed the weakest growth at 1%, while other divisions performed better.

$TJXMedAI 8/10

Should Investors Buy TJX as Growth Improves but Valuation Stays Rich?

TJX reported strong Q2 results with rising sales and raised its fiscal 2027 earnings guidance to $5.15-$5.20 per share. The company plans to expand its store count to 7,500 and accelerate growth. However, its valuation remains high, with a forward P/S ratio of 2.06, above industry and historical averages. TJX's cash flow and shareholder returns are robust, but execution and cost pressures remain risks.

$TJXHighAI 8/10

TJX Falls 17.4% in the Past Month as Strong Results Meet Key Risks

TJX Companies Inc. (TJX) shares fell 17.4% in the past month despite beating Q2 earnings estimates and raising its full-year outlook. Q2 sales rose 5% to $15.18B, but Marmaxx's 1% comparable sales growth missed expectations. Management cited merchandise mix issues. TJX faces cost pressures from wages, fuel, and currency fluctuations, with Q3 gross margin expected to decline. The stock's valuation remains high, trading at a premium to its sub-industry and historical median.

$TOLMedAI 8/10

Toll Brothers (TOL) Keeps Building Contracts As Profits Take A Hit

Toll Brothers (TOL) reported Q3 earnings with net income down to $280.1M ($2.97 per share) from $369.6M ($3.73) year-over-year. Net signed contracts rose to $2.52B from $2.41B. The company increased its share buyback plan to $700M and maintained full-year guidance. Home sales revenue is expected to be around $10.5B with a 26.1% adjusted gross margin.